A randomised controlled trial on hypolipidemic effects of Nigella Sativa seeds powder in menopausal women

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Ibrahim, Ramlah M ^a   Hamdan, Nurul S ^a   Mahmud, Rozi ^a   Imam, Mustapha U ^a   Saini, Suraini M ^a   Rashid, Saiful Nizam A ^a   Abd Ghafar, Siti A ^a   Latiff, Latiffah A ^a   Ismail, Maznah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Clinical trial; Complementary medicine; Hyperlipidemia; Menopause; Nigella sativa; Plant bioresources

Indexed keywords

HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL; ANTILIPEMIC AGENT; POWDER;

ADULT; ARTICLE; BLACK CUMIN; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID ANALYSIS; MENOPAUSE; MIDDLE AGED; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; CHEMISTRY; EMBRYOLOGY; PLANT SEED; POWDER;

FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; MENOPAUSE; MIDDLE AGED; NIGELLA SATIVA; PLACEBOS; POWDERS; SEEDS;

EID: 84899871835     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-82     Document Type: Article

References (40)

1. Sharma S, Tandon VR, Mahajan A. Menopause and cardiovascular disease. J K Sci 2008, 10:1.
2. Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric 2007, 10:19-24. 10.1080/13697130601114917, 17364594.
3. Saltiki K, Doukas C, Kanakakis J, Anastasiou E, Mantzou E, Alevizaki M. Severity of cardiovascular disease in women: relation with exposure to endogenous estrogen. Maturitas 2006, 55:51-57. 10.1016/j.maturitas.2005.12.008, 16464546.
4. World Health Organization Institute for Public Health Global status report on noncommunicable diseases. The third national health and morbidity survey 2010, Geneva: World Health Organization Press, World Health Organization Institute for Public Health.
5. Atsma F, Bartelink ML, Grobbee DE, Van Der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006, 13:265-279. 10.1097/01.gme.0000218683.97338.ea, 16645540.
6. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 western prospective studies. Circulation 2007, 115:450-458. 10.1161/CIRCULATIONAHA.106.637793, 17190864.
7. Welty FK. Cardiovascular disease and dyslipidemia in women. Arch Intern Med 2001, 16:514-522.
8. Institute of Public Health The third national health and morbidity survey (NHMS III) 2006, Malaysia: Ministry of Health, 1, Institute of Public Health.
9. Wan Ahmad WA, Sim KH. Annual report of the NCVD-PCI registry, year 2007 2009, National Cardiovascular Disease Database: Kuala Lumpur, Malaysia.
10. Pöss J, Custodis F, Werner C, Weingärtner O, Böhm M, Laufs U. Cardiovascular disease and dyslipidemia: beyond LDL. Curr Pharm Des 2011, 17:861-870. 10.2174/138161211795428858, 21418031.
11. Gurib-Fakim A. Medicinal plants; traditions of yesterday and drugs for tomorrow. Mol Asp Med 2006, 27:1-93.
12. Shrivastava RM, Agrawal RC, Parveen ZJ. A review on therapeutic applications of Nigella sativa. J Chem Chem Sci 2011, 1:241-248.
13. Khoddami A, Ghazali HM, Yassoralipour A, Ramakrishnan Y, Ganjloo A. Physicochemical characteristics of nigella seed (Nigella sativa L.) oil as affected by different extraction methods. J Am Oil Chem Soc 2011, 88:533-540.
14. Gilani AH, Jabeen Q, Khan MA. A review of medicinal uses and pharmacological activities of Nigella sativa. Pak J Biol Sci 2004, 7:441-451.
15. Sabzghabaee AM, Dianatkhah M, Sarrafzadegan N, Asgary S, Ghannadi A. Clinical evaluation of nigella sativa seedsfor the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial. Med Arh 2012, 66:198-200. 10.5455/medarh.2012.66.198-200, 22822623.
16. Sen N, Kar Y, Tekeli Y. Antioxidant activities of black cumin (Nigella sativa L.) seed cultivating in different regions in Turkey. J Food Biochem 2010, 34:105-119.
17. Bittner V. Menopause, age, and cardiovascular risk: a complex relationship. J Am Coll Cardiol 2009, 54:2374-2375. 10.1016/j.jacc.2009.10.008, 20082926.
18. Maturana MA, Breda V, Lhullier F, Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism 2008, 57:961-965. 10.1016/j.metabol.2008.02.012, 18555838.
19. Tandon VR, Mahajan A, Sharma S, Sharma A. Prevalence of cardiovascular risk factors in postmenopausal women: a rural study. J Midlife Health 2010, 1:26-29. 3139259, 21799635.
20. Mesalić L, Tupković E, Kendić S, Balić D. Correlation between hormonal and lipid status in women in menopause. Bosn J Basic Med Sci 2008, 8:188-192.
21. Feng Y, Hong X, Wilker E, Li Z, Zhang W, Jin D, Liu X, Zang T, Xu X. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008, 196:590-597. 10.1016/j.atherosclerosis.2007.06.016, 2271121, 17675039.
22. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, Ganiats TG, Gomes AS, Gornik HL, Gracia C, Gulati M, Haan CK, Judelson DR, Keenan N, Kelepouris E, Michos ED, Newby LK, Oparil S, Ouyang P, Oz MC, Petitti D, Pinn VW, Redberg RF, Scott R, Sherif K, Smith SC, Sopko G, Steinhorn RH, Stone NJ, Taubert KA, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007, 115:1481-1501. 10.1161/CIRCULATIONAHA.107.181546, 17309915.
23. Tong IL. Nonpharmacological treatment of postmenopausal symptoms. The Obstetrician & Gynaecologist 2013, 15:19-25.
24. Bair YA, Gold EB, Greendale GA, Sternfeld B, Adler SR, Azari R, Harkey M. Ethnic differences in use of complementary and alternative medicine at midlife: Longitudinal results from SWAN participants. Am J Pub Health 2002, 92:1832-1840.
25. Paarakh PM. Nigella sativa Linn- a comprehensive review. Indian J Nat Prod Resour 2010, 1:409-429.
26. El-Tahir KEH, Al-Ajmi MF, Al-Bekairi AM. Some cardiovascular effects of the dethymoquinonated Nigella sativa volatile oil and its major components α-pinene and p-cymene in rats. Saudi Pharm J 2003, 11:104-110.
27. Pourghassem-Gargari B, Ebrahimzadeh-Attary V, Rafraf M, Gorbani A. Effect of dietary supplementation with Nigella sativa L. on serum lipid profile, lipid peroxidation and antioxidant defense system in hyperlipidemic rabbits. J Med Plants Res 2009, 3:815-821.
28. Bhatti IU, Ur Rehman F, Khan MA, Marwat SK. Effect of prophetic medicine kalonji (Nigella sativa) on lipid profile of human beings. An in vivo approach. World Appl Sci J 2009, 6:1053-1057.
29. Tasawar Z, Siraj Z, Ahmad N, Lashari MH. The effects of Nigella sativa (Kalonji) on lipid profile in patients with stable coronary artery disease in Multan, Pakistan. Pak J Nutr 2011, 10:162-167.
30. Dehkordi FR, Kamkhah AF. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam Clin Pharmacol 2008, 4:447-452.
31. Padhye S, Banerjee S, Ahmad A, Mohammad R, Sarkar FH. From here to eternity-the secret of pharaohs: therapeutic potential of black cumin seeds and beyond. Cancer Ther 2008, 6:495-510. 2583426, 19018291.
32. Ismail M, Al-Naqeep G, Chan KW. Nigella sativa thymoquinone rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radic Biol Med 2010, 48:664-672. 10.1016/j.freeradbiomed.2009.12.002, 20005291.
33. Al-Naqeep G, Ismail M. Regulation of apolipoprotien a-1 and apolipoprotien B100 genes by thymoquinone rich fraction and thymoquinone in HepG2 cells. J Food Lipids 2009, 16:245-258.
34. Al-Naqeep G, Ismail M. Effects of thymoquinone rich fraction and thymoquinone on plasma lipoprotein level and hepatic low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme a Reductase gene expression. J Funct Foods 2009, 1:298-303.
35. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005, 81:317-325.
36. El-Beshbishy HA, Singab ANB, Sinkkonen J, Pihlaja K. Hypolipidemic and antioxidant effects of Morusalba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats. Life Sciences 2006, 78:2724-2733. 10.1016/j.lfs.2005.10.010, 16313926.
37. Talati R, Baker WL, Pabilonia MS, White CM, Coleman CI. The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med 2009, 7:157-163. 10.1370/afm.917, 2653960, 19273871.
38. Moruisi KG, Oosthuizen W, Opperman AM. Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analyses. J Am Coll Nutr 2006, 25:41-48. 10.1080/07315724.2006.10719513, 16522931.
39. Ramadan MF, Morsel JT. Characterization of phospholipid composition of black cumin (Nigella sativa L.) seed oil. Nahrung 2002, 46:240-244. 10.1002/1521-3803(20020701)46:4<240::AID-FOOD240>3.0.CO;2-1, 12224418.
40. Djoussé L, Hunt SC, Arnett DK. Dietary linoleic acid is inversely associated with plasma triacylglycerol: the national heart, lung, and blood institute family heart study. Am J Clin Nutr 2003, 78(6):1098-1102.